Literature DB >> 186979

[Experiments with simultaneous immunization against cytomegalovirus infection and rubella].

M Just, A Bürgin-Wolff, R Hernandez.   

Abstract

An immunisation trial with simultaneously applicated attenuated rubellavirus (Cendehill) and attenuated cytomegalovirus (TOWNE 125) was done in adults. There was no difference in antibody-titers against both viruses and in side-reactions (local ones only) between simultaneous or single application of the two viruses. Adults immunized against cytomegalovirus two years ago still had IF-IgG-antibodies; in only 1 of 8 volunteers there was a significant antibody-decline.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 186979     DOI： 10.1007/bf01998107

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN： 0303-8408


  6 in total

1.  Immunisation trials with live attenuated cytomegalovirus TOWNE 125.

Authors:  M Just; A Buergin-Wolff; G Emoedi; R Hernandez
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside.

Authors:  G Emödi; J Sartorius; M Just; F Rohner; U Bühler
Journal:  Helv Paediatr Acta       Date:  1972-12

3.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

4.  Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

Authors:  S Stagno; D W Reynolds; A Tsiantos; D A Fuccillo; W Long; C A Alford
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

5.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Separation of rubella IgM, IgA, and IgG antibodies by gel filtration on agarose.

Authors:  A Bürgin-Wolff; R Hernandez; M Just
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.